SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently testing long-term support levels near $40, sparking active debate among traders over whether this represents a value-buying opportunity or a structural decline. While bears point to persistent brand weakness and market share losses to newer competitors, bulls are closely monitoring institutional accumulation and potential catalysts like dividend yield and upcoming turnaround strategies as indicators of a long-term bottom.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as investors rally behind a breakthrough patent settlement with Samsung and growing expectations for further high-value licensing deals and settlements with major industry players like Micron and Google. The community is focused on the company's substantial patent portfolio as a critical component for AI-driven memory infrastructure, fueling active discussion about a potential short squeeze and a long-term revaluation of the stock.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Charles Schwab is currently facing significant backlash from users due to recurring system outages and technical glitches that have hindered trading capabilities during high-volatility periods. The community is actively debating the reliability of the platform compared to competitors, with many frustrated traders expressing dissatisfaction over lost profit opportunities and inadequate customer service responses.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amidst intense community debate fueled by ongoing political controversies, military tensions in the Middle East, and speculative discussions regarding the company's financial future and merger activity. Investors and critics are actively engaged in polarizing exchanges, highlighting deep-seated sentiment gaps surrounding both the stock's valuation and the broader political climate.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors digest a positive regulatory update regarding the NDA filing path for AXPAXLI, while the community actively debates its competitive positioning against EyePoint's Duravyu. Discussion is heavily focused on potential buyout prospects and the impact of upcoming data readouts on the company's valuation in the wet AMD space.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is trending as investors respond to significant expansion news, including a five-year, 55 MW data center hosting agreement valued at over $500 million with Axe Compute. Community discussions are heavily focused on the company's pivot toward AI infrastructure and modular edge data centers, with many supporters highlighting the potential for recurring revenue and the stock's positioning within the high-demand AI compute sector.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis is attracting significant attention as investors weigh a deep-value turnaround strategy against concerns over inventory bloat and ongoing production pauses. While many in the community remain skeptical of recent management shifts and the company's aggressive electrification pivot, bulls are focused on the stock's significant cash position, new product launches, and the potential for a long-term rebound as the automotive cycle bottoms out.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is facing intense selling pressure and market skepticism as investors weigh the company's high cash burn against the upcoming production ramp of the R2 model. Community members are actively debating the stock's viability, with many pointing to concerns over slow execution, management's handling of dilution, and the broader competitive threat from major automakers.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is currently experiencing high volatility following the release of updated Phase III HARMONi clinical data, which showed a statistically significant survival benefit for its lead candidate, ivonescimab, in treating advanced non-small cell lung cancer. While the community is actively debating the significance of the data and the company's path toward FDA approval, the stock is seeing heavy options activity and intense sentiment shifts as investors weigh the long-term potential of the drug against regulatory uncertainties.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors react to positive mechanistic insights regarding its pipeline, fueling optimism ahead of the Q4 BLA submission for its prostate cancer drug. The community is actively discussing the platform's potential, strong institutional backing, and a significant market opportunity that has sparked widespread interest in the company's long-term commercial trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ZS Zscaler price target raised to $200 from $180 at TD Cowen 
 
TD Cowen raised the firm&#39;s price target on Zscaler to $200 from $180 and keeps a Buy rating on the shares. The firm expects the company to report in-line or better results fiscal Q4 reports. Security demand remains healthy, driven by global conflict, high-profile breaches, and the spending prioritization of AI, the analyst tells investors in a research note. Recent competitor results indicate healthy demand for Zscaler, the analyst tells investors in a research note.

Jeremy

StockTwits Web

Zscaler Inc

 Zscaler price target raised to $200 from $180 at TD Cowen 
 
TD Cowen raised the firm's price target on Zscaler to $200 from $180 and keeps a Buy rating on the shares. The firm expects the company to report in-line or better results fiscal Q4 reports. Security demand remains healthy, driven by global conflict, high-profile breaches, and the spending prioritization of AI, the analyst tells investors in a research note. Recent competitor results indicate healthy demand for Zscaler, the analyst tells investors in a research note.